FAQs of Vaccines

FAQs VACCINE ISSUES
W. Jean Dodds, DVM
Hemopet/Hemolife
www.hemopet.org

Q. Is there risk of overvaccinating with vaccines not needed for a specific animal ?
A. Yes. Vaccines contain material designed to challenge the immune system of the pet, and so can cause adverse reactions.  They should not be given needlessly, and should be tailered to the pet’s individual needs.

Q. Are the initial series of puppy core vaccines immunosuppressive ?
A. Yes. This period of immuno suppression from MLV canine distemper and hepatitis vaccines coincides with the time of vaccine-induced viremia, from days 3 to 10 after vaccination.

Q. Can smaller doses of vaccines be given to toy dog breeds ?
A. Yes, they can, although some vaccinologists believe that the whole amount should be given because it represents the minimum immunizing dose. My view is that a half dose of vaccines, other than rabies, as required by law, should suffice and would be safer.

Q. Can anesthetized patients be vaccinated ?
A.This is not preferred, because a hypersensitivity reaction  with vomiting and aspiration could occur and anesthetic agents can be immunomodulating.

Q. Is it safe to vaccinate pregnant pets ?
A.  Absolutely not.

Q. Should pets with immunosuppressive diseases such as cancer or autoimmune diseases, or adverse vaccine reactions/ hypersensitibvity receive booster vaccinations  ?
A. No. Vaccination with MLV products should be avoided as the vaccine virus may cause disease; vaccination with killed products may aggravate the immune-mediated disease or be ineffective.  For rabies boosters that are due, local authorities may accept titers instead.

Q. If an animal receives immunosuppressive therapy, how long afterwards can the pet  safely be vaccinated ?
A.  Wait at least 2 weeks.

Q. Should vaccines be given more often that 2 weeks apart even if a different vaccine is being given ?
A. No. The safest and most effective interval is 3-4 weeks apart.

Q.  At what age should the last vaccine dose be given in the puppy and kitten series ?
A. The last dose of vaccine should be given between 14-16 weeks.  Rabies vaccine should preferably be given separately as late as possible under the law (e.g. 20-24 weeks).

Q. Can intranasal Bordetella vaccine be given parenterally ?
A. No. The vaccine can cause a severe local reaction and may even kill the pet.

Q. Will a killed parenteral Bordetella vaccine given intranasally produce immunity ?
A. No.

Q.  Can MLV parenteral vaccines for cats be used intranasally ?
A. Never. Any mucosal (e.g. conjunctival and nasal) contact with these vaccines can cause disease.

Q. Are homeopathic nosodes capable of immunizing pets ?
A. No. There is no scientific documentation that nosodes protect against infectious diseases of pets. The one parvovirus nosode trial conducted years ago did not protect against challenge.

Q. Should disinfectant be used at the vaccine injection site?
A. No. Disinfectants could inactivate a MLV product.

Q. Can vaccines cause autoimmune diseases?
A. Vaccines themselves do not cause these diseases, but they can trigger autoimmune responses followed by disease in genetically predisposed animals, as can any infection, drug, or chemical / toxic exposures etc.

Q. Can a single vaccine dose provide any benefit to the dog or cat? Will it benefit the canine and feline populations?
A. Yes. One dose of a MLV canine or feline core vaccine should provide long term immunity when given to animals at or after 16 weeks of age. Every puppy and kitten 16 weeks of age or older should receive at least one dose of the MLV core vaccines. We need to vaccinate more animals in the population with core vaccines to achieve herd immunity (e.g. 75% or higher, when probably only 50% of dogs and 25% of cats are vaccinated) and thereby prevent epidemic outbreaks.

Q. If an animal receives only the first dose of a vaccine that needs two doses to immunize, will it have immunity ?
A. No. A single dose of a two-dose vaccine like Leptospirosis or feline leukemia vaccine will not provide immunity. The first dose is for priming the immune system. The second for boosting the immunity has to be given within 6 weeks; otherwise the series has to start over again. After those two doses, revaccination with a single dose can be done at any time.

Q. Can maternally derived antibodies (MDA) also block immunity to killed vaccines and prevent active immunization with MLV vaccines ?
A. Yes. MDA can block certain killed vaccines, especially those that require two doses to immunize.  With MLV vaccines, two doses are often recommended, particularly in young animals, to be sure one is given beyond the neutralizing period of MDA.

Q. How long after vaccination does an animal develop immunity that will prevent severe disease when the core vaccines are used?
A. This is dependent on the animal, the vaccine, and the disease.
· The fastest immunity is provided by CDV vaccines — MLV and recombinant canarypox virus vectored. The immune response starts within mins – hrs and provides protection within a day without interference from MDA.
· Immunity to CPV-2 and FPV develops after 3-5 days when an effective ML V vaccine is used. In contrast, killed FPV-2 vaccine often takes 2 – 3 wks or longer to provide protective immunity.
· CAV-2 MLV given parenterally provides immunity against CAV-1 in 5 to 7 days.
· Time from vaccination to immunity is difficult to determine for FCV and FHV-1 because some animals will not develop any immunity.

Q. Can dogs and cats be non-responders and fail to develop an immune response to vaccines  ?
A. Yes. This is a genetic characteristic seen particularly in some breeds or dog families. Boosting them regularly will not produce measurable circulating immunity, but they may be protected against disease by their cell-mediated and secretory immunity.

Q. Are there parvovirus and distemper virus field mutants that are not adequately protected by current MLV vaccines ?
A. No. All the current CPV-2 and CDV vaccines provide protection from all known viral isolates, when tested experimentally as well as in the field. The current CPV-2 and CPV-2b vaccines provide both short and long term protection from challenge by the CPV-2c variant.

Q. Are serum antibody titres useful in determining vaccine immunity?
A. Yes.  They are especially useful for CDV, CPV-2 and CAV-1 in the dog, FPV in the cat, and rabies virus in the cat and dog. Rabies titers, however, are often not acceptable to exempt individual animals from mandated rabies boosters in spite of medical justifcation.  Serum antibody titers are of limited or no value for the other vaccines.

*  Excerpted from : J  Sm An Pract 48, 528 541, 2007.

Canine Influenza Vaccine Found Effective Against Secondary Infections

Recent research by Ron Schultz, professor and chair of the Department of Pathobiological Sciences at the University of Wisconsin-Madison School of Veterinary Medicine, has shown the newly approved Canine Influenza Virus (CIV) vaccine to be effective not only in reducing length, severity and spread of the virus, but also in protecting against secondary infections.
Continue reading Canine Influenza Vaccine Found Effective Against Secondary Infections

New canine flu vaccine

24 Jun 2009
Canine influenza was first identified in the United States in 2004. Since then, CIV has continued to spread and has now been detected in dogs in 30 states and the District of Columbia, according to Dr. Crawford and Edward J. Dubovi, Ph.D., Professor of Virology, Cornell University College of Veterinary Medicine, two of the nation’s leading experts on Canine H3N8 who have been tracking the disease since 2004. Continue reading New canine flu vaccine

Low Cost rabies screen for veterinarians

05 Feb 2009
Dyne Immune, LLC announced their new, portable Rabies RAPIDâ„¢ (Rapid Antibody Portable Immunodetection) Screen, which can detect the presence of rabies in an animal saliva sample within 30 minutes, providing vital information much sooner than traditional testing methods.
Continue reading Low Cost rabies screen for veterinarians

wintertime rabies bait drop

Texas DSHS To Resume Annual Wintertime Rabies Bait Drop Jan. 7

04 Jan 2009
The Texas Department of State Health Services’ annual airdrop of vaccine baits, credited with turning the tide against the spread of rabies strains carried by coyotes and gray foxes, will begin next week. Some 2.9 million baits will be dropped over parts of 41 Texas counties. Continue reading wintertime rabies bait drop

New strain of canine parvo virus

A team of Oklahoma State University (OSU) veterinarians, virologists and pathologists at the Oklahoma Animal Disease Diagnostic Laboratory (OADDL) recently published a paper in the Journal of Clinical Microbiology on their findings from a Canine parvovirus (CPV) study. Led by Dr. Sanjay Kapil, the group is the first to describe the CPV type 2c variant in the United States. Continue reading New strain of canine parvo virus